NCT02141191View on ClinicalTrials.gov

A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD Device

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Cystic Fibrosis
Interventions
DRUG

inhaled hypertonic saline (7%)

Inhaled hypertonic saline delivered by nasal cannula using the Parion transnasal Pulmonary Aerosol Delivery (tPAD) device

Trial Locations (1)

15213

University of Pittsburgh, Pittsburgh

Sponsors

Collaborators (1)

Parion Sciences
All Listed Sponsors
collaborator

Parion Sciences

INDUSTRY

lead

University of Pittsburgh

OTHER

NCT02141191 - A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD Device | Biotech Hunter | Biotech Hunter